Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 4;79(3):614–628. doi: 10.1161/HYPERTENSIONAHA.121.18415

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors.

Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.

PMC Copyright notice

Figure 1. — League table comparing primary drugs of interest with placebo/no therapy and with each other. All estimates are odds ratios (OR) and 95% credible intervals. Outcomes are (from top left to bottom right): severe hypertension (A), proteinuria (B), perinatal death (C), small-for-gestational age infants (D), preterm birth (E), and neonatal care unit admission (F). Blue represents an OR >1.0 and orange an OR <1.0, stronger effects are illustrated by darker colors, drugs with more favourable effects are located in columns to the left, and statistically significant results (at P<0.05) are marked by double asterisks.